New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia

被引:12
作者
Cox, MC [1 ]
Panetta, P [1 ]
Venditti, A [1 ]
Abruzzese, E [1 ]
Del Poeta, G [1 ]
Cantonetti, M [1 ]
Amadori, S [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Hematol, Osped S Eugenio, I-00144 Rome, Italy
关键词
idiopathic myelofibrosis; chromosome translocation; eosinophilia; AML-M5; MPD;
D O I
10.1016/S0145-2126(00)00136-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Idiopathic myelofibrosis (IM), is a chronic myeloproliferative disorder (MPD) characterised by marrow fibrosis, extramedullary haematopoiesis and a leuco-erythroblastic picture of the peripheral blood. Cytogenetic data of IM is scarce: no specific karyotypic anomalies have been yet described. Trisomy 1q, del(13q), del(20q) and trisomy 8, appear in two-thirds of the cases with chromosome aberrations. We report on a 41-year-old patient diagnosed with IM associated with eosinophilia, bearing a novel translocation t(6;10)(q27;q11) as the sole chromosome anomaly. The patient, progressed to AML-M5a within 18 months from diagnosis. Recently new specific chromosomal translocations have been described in chronic MPD. These findings have allowed the classification of new syndromes with defined molecular abnormalities. The case we describe, because of the peculiar clinical features and the association with a previously unreported chromosomal translocation, might be a noteworthy addition. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:349 / 351
页数:3
相关论文
共 18 条
[1]  
Bain BJ, 1996, BRIT J HAEMATOL, V95, P2
[2]   Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups [J].
Cervantes, F ;
Barosi, G ;
Demory, JL ;
Reilly, J ;
Guarnone, R ;
Dupriez, B ;
Pereira, A ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :684-690
[3]   Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis [J].
Cervantes, F ;
Pereira, A ;
Esteve, J ;
Rafel, M ;
Cobo, F ;
Rozman, C ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :635-640
[4]   ISSUES IN THE PATHOLOGY AND DIAGNOSIS OF THE CHRONIC MYELOPROLIFERATIVE DISORDERS AND THE MYELODYSPLASTIC SYNDROMES [J].
DICKSTEIN, JI ;
VARDIMAN, JW .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (04) :513-525
[5]  
Dupriez B, 1996, BLOOD, V88, P1013
[6]  
KULKARNI S, 1999, FUSION H4D10S170 PDG
[7]  
MARTIAT P, 1991, BLOOD, V78, P205
[8]  
MCDONALD D, 1995, LEUKEMIA, V9, P1628
[9]   The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1 [J].
Popovici, C ;
Zhang, B ;
Grégoire, MJ ;
Jonveaux, P ;
Lafage-Pochitaloff, M ;
Birnbaum, D ;
Pébusque, MJ .
BLOOD, 1999, 93 (04) :1381-1389
[10]   Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases [J].
Reilly, JT ;
Snowden, JA ;
Spearing, RL ;
Fitzgerald, PM ;
Jones, N ;
Watmore, A ;
Potter, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) :96-102